4//SEC Filing
Krop Julie 4
Accession 0001179110-18-003694
CIK 0000792977other
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 7:23 PM ET
Size
11.5 KB
Accession
0001179110-18-003694
Insider Transaction Report
Form 4
Krop Julie
SVP Clinical & Regulatory, CMO
Transactions
- Award
Common Stock
2018-03-02+13,000→ 41,336 total - Award
Common Stock
2018-03-02+12,000→ 53,336 total - Tax Payment
Common Stock
2018-03-02$21.00/sh−1,700$35,700→ 51,636 total - Award
Stock Option (Right to Buy)
2018-03-02+22,000→ 22,000 totalExercise: $21.00Exp: 2028-03-02→ Common Stock (22,000 underlying)
Footnotes (6)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Common Stock of AMAG Pharmaceuticals, Inc. (the "Issuer").
- [F2]These shares of Common Stock are issuable pursuant to a grant of RSUs pursuant to the Issuer's Fourth Amended and Restated 2007 Equity Incentive Plan (as amended the "Plan") and will vest in three equal annual installments with the first installment vesting on March 2, 2019.
- [F3]Not applicable.
- [F4]These shares of Common Stock are issuable pursuant to a performance-based RSU grant under a long-term incentive program under the Plan and will be earned, if at all, based on achievement of certain relative total stockholder return targets over the three year performance period ending March 1, 2021 subject to continuation of a business relationship with the grantee through the conclusion of the performance period. The number above represents the target number of shares that may be delivered pursuant to the award ("Target Award"); however, the amount that vests could range from zero to 150% of the Target Award.
- [F5]Represents shares withheld to satisfy the reporting person's tax obligations in connection with the vesting of 2,499 RSUs on February 23, 2018 and 3,000 RSUs on March 1, 2018. Due to the black-out policies implemented by the Issuer, the shares of the Issuer's Common Stock underlying such vested RSUs were not delivered to the reporting person until March 2, 2018, at which time an aggregate of 1,700 shares were withheld to satisfy the reporting person's applicable tax obligations.
- [F6]Grant of stock option pursuant to the Plan. This option will vest and become exercisable over four years after the grant date as follows: (i) 25% on the first anniversary of the grant date and (ii) the balance vesting in equal quarterly installments over the next three years thereafter.
Documents
Issuer
AMAG PHARMACEUTICALS INC.
CIK 0000792977
Entity typeother
Related Parties
1- filerCIK 0001643127
Filing Metadata
- Form type
- 4
- Filed
- Mar 5, 7:00 PM ET
- Accepted
- Mar 6, 7:23 PM ET
- Size
- 11.5 KB